Phase II biotransformation enzymes involved in phase I biotransformation of the anti-cancer drug oracin in man

Abstract

New feature of phase II enzymes was revealed and their contribution to the reduction of carbonyl group was found and described. Microsomal glutathione-S-transferase was proved to take part in the reduction of anti-cancer drug oracin